No abstract available
MeSH terms
-
Antirheumatic Agents / administration & dosage*
-
Antirheumatic Agents / economics
-
Arthritis, Rheumatoid / drug therapy*
-
Cost-Benefit Analysis
-
Disease Progression
-
Drug Approval / legislation & jurisprudence*
-
Drug Costs / legislation & jurisprudence
-
Drug Therapy, Combination
-
Ethics, Medical*
-
Germany
-
Humans
-
Immunosuppressive Agents / administration & dosage*
-
Immunosuppressive Agents / economics
-
Insurance Coverage / economics
-
Insurance Coverage / legislation & jurisprudence*
-
Insurance, Pharmaceutical Services / economics
-
Insurance, Pharmaceutical Services / legislation & jurisprudence*
-
Male
-
Methotrexate / administration & dosage*
-
Methotrexate / economics
-
Middle Aged
-
Mycophenolic Acid / administration & dosage*
-
Mycophenolic Acid / analogs & derivatives
-
Mycophenolic Acid / economics
-
National Health Programs / economics
-
National Health Programs / legislation & jurisprudence*
-
Refusal to Treat / legislation & jurisprudence*
-
Treatment Outcome
Substances
-
Antirheumatic Agents
-
Immunosuppressive Agents
-
Mycophenolic Acid
-
Methotrexate